Jyotsna Ghai - 02 Jan 2025 Form 4 Insider Report for Singular Genomics Systems, Inc.

Role: Chief Operating Officer
Signature: /s/ Dalen Meeter, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 02 Jan 2025
Net transactions value: $0
Form type: 4
Filing time: 06 Jan 2025, 18:48:09 UTC
Previous filing: 13 Nov 2024
Next filing: 11 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OMIC	Common Stock	Options Exercise		+417	+16%		3,033	02 Jan 2025	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OMIC	Restricted Stock Units	Options Exercise		-417	-8.3%		4,583	02 Jan 2025	Common Stock	417		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2	Includes 100 shares acquired under the Issuer's employee stock purchase plan since the Reporting Person last filed a Form 4 with the Securities and Exchange Commission.
F3	Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F4	25% of the RSUs vested on October 2, 2024; the remainder of the RSUs vest in 12 equal quarterly installments thereafter, beginning on January 2, 2025.